rs587781851
Positions:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The NM_000038.6(APC):โc.5501_5506delโ(p.Val1834_Arg1835del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000236 in 1,612,888 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: ๐ 0.000039 ( 0 hom., cov: 32)
Exomes ๐: 0.000022 ( 0 hom. )
Consequence
APC
NM_000038.6 inframe_deletion
NM_000038.6 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.38
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_000038.6.
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APC | NM_000038.6 | c.5501_5506del | p.Val1834_Arg1835del | inframe_deletion | 16/16 | ENST00000257430.9 | NP_000029.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.5501_5506del | p.Val1834_Arg1835del | inframe_deletion | 16/16 | 5 | NM_000038.6 | ENSP00000257430 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152152Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250850Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135572
GnomAD3 exomes
AF:
AC:
11
AN:
250850
Hom.:
AF XY:
AC XY:
6
AN XY:
135572
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1460618Hom.: 0 AF XY: 0.0000261 AC XY: 19AN XY: 726672
GnomAD4 exome
AF:
AC:
32
AN:
1460618
Hom.:
AF XY:
AC XY:
19
AN XY:
726672
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74454
GnomAD4 genome
AF:
AC:
6
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:8Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Familial adenomatous polyposis 1 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | This variant, c.5501_5506del, results in the deletion of 2 amino acid(s) of the APC protein (p.Val1834_Arg1835del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs587778029, gnomAD 0.02%). This variant has been observed in individual(s) with colorectal cancer and/or multiple colorectal polyps (PMID: 25604157, 34347074; Invitae). ClinVar contains an entry for this variant (Variation ID: 141574). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Sep 30, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Feb 17, 2023 | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. - |
Hereditary cancer-predisposing syndrome Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.5501_5506delTCAGAG variant (also known as p.V1834_R1835del), located in coding exon 15 of the APC gene,results from an in-frame deletion of 6 nucleotides at positions 5501 to 5506 and the removal of two well-conserved residues at codons 1834 and 1835. This alteration was detected in two affected siblings, one with 100 colorectal polyps and one with with colon cancer and polyps. In addition, this alteration was also detected in two unaffected relatives from this family, but was not detected in a third affected relative (Out AA et al. Fam. Cancer. 2015 Jun;14:247-57). This amino acid region is well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Aug 27, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Nov 28, 2022 | This variant causes an in-frame deletion of two amino acids in exon 16 of the APC protein. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual affected with adenomatous polyps (PMID: 25604157), an individual with colorectal cancer (PMID: 34347074), as well as in a healthy individual (PMID: 24728327). This variant has been identified in 15/282250 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 29, 2020 | This variant is associated with the following publications: (PMID: 25604157) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jul 19, 2023 | In the published literature, this variant has been reported in individuals with colorectal cancer and/or multiple polyps, with inconclusive segregation with disease in one family (PMIDs: 34347074 (2022), 25604157 (2015)). In addition, this variant has been reported in a healthy individual under the age of 50 (PMID: 24728327 (2014)), and observed to co-occur with a pathogenic variant in the APC gene in an individual in our internal patient population, suggesting it was not the primary cause of disease. The frequency of this variant in the general population, 0.00016 (5/30610 chromosomes in South Asian subpopulation (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is higher than would generally be expected for pathogenic variants in this gene. Based on the available information, we are unable to determine the clinical significance of this variant. - |
not specified Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 08, 2019 | Variant summary: APC c.5501_5506delTCAGAG (p.Val1834_Arg1835del) results in an in-frame deletion that is predicted to remove 2 amino acids from the encoded protein. The variant allele was found at a frequency of 5.1e-05 in 276620 control chromosomes, predominantly at a frequency of 0.00016 within the South Asian subpopulation in the gnomAD database. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.5501_5506delTCAGAG has been reported in the literature in a family affected with Familial Adenomatous Polyposis, where this variant did not segregate with disease (Out_2015). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at